Home/Filings/4/A/0001209191-22-033984
4/A//SEC Filing

Greenway Schond L. 4/A

Accession 0001209191-22-033984

CIK 0001813814other

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 4:06 PM ET

Size

8.1 KB

Accession

0001209191-22-033984

Insider Transaction Report

Form 4/AAmended
Period: 2022-05-23
Greenway Schond L.
Chief Financial Officer
Transactions
  • Award

    Subordinate Voting Shares

    2022-05-23+1,270,0001,270,000 total
  • Award

    Stock Option (Right to Buy)

    2022-05-23+1,650,0001,650,000 total
    Exercise: $0.78Exp: 2027-05-22Subordinate Voting Shares (1,650,000 underlying)
Footnotes (3)
  • [F1]These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one subordinate voting share of the Issuer. Of these RSUs, 25% shall vest on May 23, 2023 with 1/12th of the remaining shares vesting each quarter thereafter over 12 quarters, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date.
  • [F2]The option grant has an exercise price of $1.00 Canadian Dollars. This represents the exercise price in United States Dollars.
  • [F3]The shares subject to the option vest and become exercisable, with 25% vesting on May 23, 2023, and 1/36th of the remaining shares vesting monthly thereafter over 36 months, subject to the Reporting Person providing continuous service to the Issuer as of each such vesting date.

Issuer

Mind Medicine (MindMed) Inc.

CIK 0001813814

Entity typeother

Related Parties

1
  • filerCIK 0001848205

Filing Metadata

Form type
4/A
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:06 PM ET
Size
8.1 KB